Session Details
[27-08-am]Mass spectrometry analysis 2
Thu. Mar 27, 2025 10:04 AM - 11:28 AM JST
Thu. Mar 27, 2025 1:04 AM - 2:28 AM UTC
Thu. Mar 27, 2025 1:04 AM - 2:28 AM UTC
Room 8 (Fukuoka International Congress Center: 409+410 [4F])
Chair: Kenichiro Todoroki, Atsushi Taga
[27-08-am08]Development of a novel highly sensitive ion-pairing reagent-free LC-MS method for oligonucleotide therapeutics
○Yuchen Sun1, Ruri Kikura-Hanajiri1, Yoshiharu Hayashi2 (1. Div. Medicinal Safety Science, NIHS, 2. CMIC Pharma Science Co., Ltd.)
[27-08-am09S]Development of high-sensitivity sample preparation methods in bottom-up proteomics
○Akane Omori1, Shunsuke Tanaka2, Ayana Tomioka2, Kosuke Ogata1,2, Eisuke Kanao1,2,3, Yasushi Ishihama1,2,3 (1. Pharm. Sci., Kyoto Univ., 2. Grad. Sch. Pharm. Sci., Kyoto Univ., 3. NIBIOHN)
[27-08-am10S]Large-scale analysis of proteolysis in non-small cell lung cancer cell lines using protein terminomics
○Risa Chisaka1, Yuto Taniguchi1, Tatsuya Sagawa1, Kaho Takamuro2, Ayana Tomioka1, Hiroshi Nishida1, Shujiro Okuda3, Yasushi Ishihama1 (1. Grad. Sch. of Pharm. Sci. Kyoto Univ. , 2. Faculty of Pharm. Kyoto Univ. , 3. Niigata Univ. Sch. of Medicine.)
[27-08-am11S]Development of peptide probes for large-scale activity profiling of tyrosine phosphatase
○Fumika Mori1, Tomoya Niinae2, Kosuke Ogata1,2, Eisuke Kanao1,2,3, Yasushi Ishihama1,2,3 (1. Pharm. Sci., Kyoto Univ., 2. Grad. Sch. Pharm. Sci., Kyoto Univ., 3. NIBIOHN)
[27-08-am12S]Large-scale measurement of protein N-terminal acetylation and correlation analysis with protein half-life
○Akane Takeshita1, Eisuke Kanao1,2,3, Koshi Imami4, Yasushi Ishihama1,2,3 (1. Pharm. Sci., Kyoto Univ., 2. Grad. Sch. Pharm. Sci., Kyoto Univ., 3. NIBIOHN, 4. IMS, RIKEN)
[27-08-am13S]Large-scale measurement of proteoform lifetimes by pulse SILAC and protein terminal enrichment
○Ema Okumura1, Kosuke Ogata1,2, Eisuke Kanao1,2,3, Yasushi Ishihama1,2,3 (1. Pharm. Sci., Kyoto Univ., 2. Grad. Sch. Pharm. Sci., Kyoto Univ., 3. NIBIOHN)
[27-08-am14S]Protein structural analysis based on MS silencing technology
○Karin Arima1, Asato Maeda2, Kosuke Ogata1,2, Eisuke Kanao1,2,3, Yasushi Ishihama1,2,3 (1. Fac. Pharm. Sci., Kyoto Univ., 2. Grad. Sch. Pharm. Sci., Kyoto Univ., 3. NIBIOHN)